Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival

Journal of Clinical Oncology

Volumn 21, Issue 11, 2003, Pages 2085-2093

  Ratschiller, D ^a   Heighway, J ^a   Gugger, M ^a   Kappeler, A ^a   Pirnia, F ^a   Schmid, R A ^a   Borner, M M ^a   Betticher, D C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY;

ALLELE; ARTICLE; BRONCHUS MUCOSA; CANCER LOCALIZATION; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MICRODISSECTION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADULT; AGED; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RESPIRATORY TRACT MUCOSA; SMOKING; SURVIVAL RATE; SWITZERLAND;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESPIRATORY MUCOSA; SMOKING; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; SWITZERLAND;

EID: 0037868819     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.03.103     Document Type: Article

References (31)

1. Shopland DR, Eyre HJ, Pechacek TF: Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83:1142-1148, 1991
2. Slaughter DP, Southwick HW, Smejkal W: "Field cancerization" in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer 6:963-968, 1953
3. Grover FL, Piantadosi S: Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung: The Lung Cancer Study Group experience. Ann Surg 209:779-790, 1989
4. Wistuba II, Lam S, Behrens C, et al: Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89:1366-1373, 1997
5. Mao L, Lee JS, Kurie JM, et al: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89:857-862, 1997
6. Kishimoto Y, Sugio K, Hung JY, et al: Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 87:1224-1229, 1995
7. Gazdar AF, Lam S, Wistuba II: Molecular and cytologic techniques of early detection, in: Pass HI, Mitchell JB, Johnson DH, et al (eds): Lung Cancer: Principles and Practice (ed 2). Philadelphia, PA, Lippincott, Williams & Wilkins, 2000, pp 407-424
8. Caballero OL, Cohen D, Liu Q, et al: Loss of chromosome arms 3p and 9p and inactivation of P16 (INK4a) in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer 32:119-125, 2001
9. Franklin WA, Gazdar AF, Haney J, et al: Widely dispersed p53 mutation in respiratory epithelium: A novel mechanism for field carcinogenesis. J Clin Invest 100:2133-2137, 1997
10. Betticher DC, Thatcher N, Altermatt HJ, et al: Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11:1005-1011, 1995
11. Betticher DC, Heighway J, Hasleton PS, et al: Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73:294-300, 1996
12. Betticher DC, Heighway J, Thatcher N, et al: Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer 75:1761-1768, 1997
13. Brambilla E, Gazzeri S, Moro D, et al: Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res 5:243-250, 1999
14. Lonardo F, Rusch V, Langenfeld J, et al: Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 59:2470-2476, 1999
15. Mountain CF: The new International Staging System for Lung Cancer. Surg Clin North Am 67:925-935, 1987
16. Travis W, Colby T, Corrin B, et al: Histological Typing of Lung and Pleural Tumours (ed 3). Berlin, Germany, Springer, 1999
17. Fink L, Seeger W, Ermert L, et al: Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4:1329-1333, 1998
18. Heighway J: HaeIII polymorphism within 3′ untranslated region of PRAD1. Nucleic Acids Res 19:5451, 1991
19. Cox D: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
20. McKay JA, Douglas JJ, Ross VG, et al: Cyclin D1 protein expression and gene polymorphism in colorectal cancer: Aberdeen Colorectal Initiative. Int J Cancer 88:77-81, 2000
21. Marsh KL, Varley JM: Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer 77:1460-1468, 1998
22. Arber N, Hibshoosh H, Moss SF, et al: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110:669-674, 1996
23. Palmqvist R, Stenling R, Oberg A, et al: Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 34:1575-1581, 1998
24. Diehl JA, Sherr CJ: A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol Cell Biol 17:7362-7374, 1997
25. LaBaer J, Garrett MD, Stevenson LF, et al: New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862, 1997
26. Vonlanthen S, Heighway J, Rappeler A, et al: p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer. Int J Oncol 16:951-957, 2000
27. Cheng M, Olivier P, Diehl JA, et al: The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583, 1999
28. Sueoka N, Lee HY, Walsh GL, et al: Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Cancer Res 59:3838-3844, 1999
29. Omenn GS, Goodman GE, Thornquist MD, et al: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155, 1996
30. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029-1035, 1994
31. Langenfeld J, Kiyokawa H, Sekula D, et al: Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism. Proc Natl Acad Sci U S A 94:12070-12074, 1997